{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T06:38:37Z","timestamp":1712039917435},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T00:00:00Z","timestamp":1153094400000},"content-version":"vor","delay-in-days":4141,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1995,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several correlative experimental approaches have provided evidence that polyclonal serum natural antibodies (NAb) participate in the defense against small syngeneic tumor foci <jats:italic>in vivo.<\/jats:italic> The threshold subcutaneous tumor inoculum model of incipient neoplasia has consistently revealed an inverse relationship between tumorigenicity <jats:italic>in vivo.<\/jats:italic> and the NAb binding capacity of the tumor injected or the anti\u2010tumor NAb levels of the recipient animals, including B cell\u2014deficient mice bearing the xid mutation of the CBA\/N mouse strain. Now passive i.v. administration of whole normal syngeneic serum NAb in bolus injections, given I each day beginning on day \u20102, \u2010 I or 0 prior to the threshold s.c. challenge of xid\u2010bearing CBA\/N or male (CBA\/N \u00d7 CBA\/ J)F<jats:sub>1<\/jats:sub> mice with syngeneic RI\u201028 lymphoma cells, consistently and significantly reduced their tumorigenicity assayed as tumor appearance and latency. Three similar injections of an ammonium sulfate\u2014precipitated fraction of whole serum NAb also reduced tumor frequency and latency, while a combination of purified IgG and IgM NAb reduced the appearance of tumors slightly and increased the survival of recipients. The reconstitution of the xid\u2010defect in anti\u2010tumor NAb provides more direct evidence to substantiate a role for NAb in the defense against early tumor development in vivo and establishes a model for the dissection of the <jats:italic>in vivo.<\/jats:italic> mechanisms of the NAb anti\u2010tumor activity.<\/jats:p>","DOI":"10.1002\/ijc.2910600621","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T00:38:49Z","timestamp":1171931929000},"page":"848-853","source":"Crossref","is-referenced-by-count":8,"title":["Reduced tumorigenicity of threshold syngeneic tumor inocula in XID\u2010bearing mice treated with natural antibodies"],"prefix":"10.1002","volume":"60","author":[{"given":"Donna A.","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(88)90017-X"},{"key":"e_1_2_1_3_1","unstructured":"Bennet R. D.andChow D. A. Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid\u2010bearing mice. Nat. Immun. Cell Growth Regul. 45\u201355(1991)."},{"issue":"2","key":"e_1_2_1_4_1","first-page":"14","article-title":"Recent advances in the treatment of chronic lymphocytic leukemia: delimits the role of intravenous immunoglobulin","volume":"26","author":"Besa E. C.","year":"1992","journal-title":"Sem. Hematol."},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.136.8.3116","article-title":"Phenotypic alterations in tumors that developed from threshold subcutaneous inocula I. Redueed binding of natural antibodies and sensitivity to hypotonic lysis","volume":"136","author":"Brown G. W.","year":"1986","journal-title":"J. Immunol."},{"key":"e_1_2_1_6_1","first-page":"325","article-title":"Human anti\u2010alphagalactosyl IgG reduces the lung colonization by murine MO4 cells","volume":"7","author":"Castkonovo V.","year":"1987","journal-title":"Invasion Metastasis."},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.4049\/jimmunol.142.10.3702","article-title":"Low natural antibody and low in vivo. tumor resistance in xid\u2010bearing Beell deficient mice","volume":"142","author":"Chow D. A.","year":"1989","journal-title":"J. Immunol."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910270407"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(84)80008-6"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916938908997101"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420115"},{"issue":"1","key":"e_1_2_1_12_1","first-page":"121","article-title":"Immunomodulating therapy of systemic juvenile rheumatoid arthritis: administration of high\u2010dose intravenous gamma globulin","volume":"20","author":"Horneff G.","year":"1993","journal-title":"Infusionsther\u2010Transfusionsmed."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-155-39779"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910280510"},{"key":"e_1_2_1_15_1","first-page":"5235","article-title":"Tumor progression in vivo: increased soybean agglutinin lectin binding, N\u2010acetylgalactosamine specific lectin expression and liver metastasis potential","volume":"52","author":"Reese M. R.","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199206000-00020"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60834-2"},{"key":"e_1_2_1_18_1","first-page":"497","article-title":"Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3\u2032:5\u2032 monophosphate levels, resulting in suppression of tumor necrosis factor alpha and interleukin\u20101 production","volume":"72","author":"Shimozato T.","year":"1991","journal-title":"Immunology"},{"key":"e_1_2_1_19_1","first-page":"270","article-title":"Tumorigenicity of murine lymphomas selected through fluorescence\u2010detected natural antibody binding","volume":"48","author":"Tough D. F.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_1_20_1","first-page":"83","article-title":"Natural antibody recognition of v\u2010H\u2010ras\u2010induced 10T1\/2 transformation","volume":"10","author":"Tough D. F.","year":"1991","journal-title":"Nat. Immun. Cell Growth Regui."},{"key":"e_1_2_1_21_1","unstructured":"Tough D. F. Feng X.andChow D. A. p21\u2010independent downregulation of ras\u2010induced increases in natural antibody binding during tumor progression. Nat. Immun. (1995). (In press)."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500317"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00920789"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910600621","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910600621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:10:53Z","timestamp":1698261053000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910600621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3,16]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,3,16]]}},"alternative-id":["10.1002\/ijc.2910600621"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910600621","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3,16]]}}}